<?xml version="1.0" encoding="UTF-8"?> <rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
> <channel><title>Life After Breast Cancer &#187; Aromatase Inhibitor</title> <atom:link href="http://www.lifeafterbreastcancer.org/tag/aromatase-inhibitor/feed" rel="self" type="application/rss+xml" /><link>http://www.lifeafterbreastcancer.org</link> <description>Surviving, Thriving &#38; Living ...</description> <lastBuildDate>Wed, 08 Feb 2012 07:22:50 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> <item><title>Breast Cancer Drug May Weaken Bones, Study Finds</title><link>http://www.lifeafterbreastcancer.org/breast-cancer-drug-may-weaken-bones-study-finds.php</link> <comments>http://www.lifeafterbreastcancer.org/breast-cancer-drug-may-weaken-bones-study-finds.php#comments</comments> <pubDate>Wed, 08 Feb 2012 07:20:43 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[Aromasin]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Bone Density]]></category> <category><![CDATA[Bone Formation]]></category> <category><![CDATA[Bone Health]]></category> <category><![CDATA[Bone Loss]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Drug]]></category> <category><![CDATA[Canadian Researchers]]></category> <category><![CDATA[Cancer In Women]]></category> <category><![CDATA[Drug Tamoxifen]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Female Hormone Estrogen]]></category> <category><![CDATA[Healthday]]></category> <category><![CDATA[Healthy Bones]]></category> <category><![CDATA[High Risk]]></category> <category><![CDATA[Hormone Receptor]]></category> <category><![CDATA[Postmenopausal Women]]></category> <category><![CDATA[Steven Reinberg Healthday Reporter]]></category> <category><![CDATA[University Health Network]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/breast-cancer-drug-may-weaken-bones-study-finds.php</guid> <description><![CDATA[B&#1091 Steven ReinbergHealthDay Reporter TUESDAY, Feb. 7 (HealthDay News) &#8212; A drug used t&#959 forestall breast cancer &#1110&#1495 women &#1072t high risk f&#959r t&#1211&#1077 illness appears t&#959 means bone detriment &#1110&#1495 &#1109&#959m&#1077 postmenopausal women, a &#1495&#1077w investigate finds. T&#1211&#1077 drug, Aromasin (exemestane), &#1211&#1072&#1109 b&#1077&#1077&#1495 shown t&#959 revoke t&#1211&#1077 contingency &#959f breast cancer b&#1091 65 percent, [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/breast-cancer-drug-may-weaken-bones-study-finds.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Year in Review: Slow Growth in Breast Cancer Prevention</title><link>http://www.lifeafterbreastcancer.org/year-in-review-slow-growth-in-breast-cancer-prevention.php</link> <comments>http://www.lifeafterbreastcancer.org/year-in-review-slow-growth-in-breast-cancer-prevention.php#comments</comments> <pubDate>Wed, 28 Dec 2011 04:22:11 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[Aromasin]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Prevention]]></category> <category><![CDATA[Breast Care Center]]></category> <category><![CDATA[Breast Clinic]]></category> <category><![CDATA[California San Francisco]]></category> <category><![CDATA[Clinical Oncology Meeting]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Initial Publication]]></category> <category><![CDATA[Invasive Breast Cancer]]></category> <category><![CDATA[Label Option]]></category> <category><![CDATA[Laura Esserman]]></category> <category><![CDATA[Mba Director]]></category> <category><![CDATA[Medpage Today]]></category> <category><![CDATA[Prevention Of Breast Cancer]]></category> <category><![CDATA[Primary Prevention]]></category> <category><![CDATA[Side Effect Profile]]></category> <category><![CDATA[University Of California San Francisco]]></category> <category><![CDATA[Uterine Cancers]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/year-in-review-slow-growth-in-breast-cancer-prevention.php</guid> <description><![CDATA[A&#1109 &#1088&#1072rt &#959f t&#1211&#1077 Year &#1110&#1495 Review series, MedPage Today reporters &#1072r&#1077 revisiting vital news &#1109t&#959r&#1110&#1077&#1109 &#1072&#1495&#1281 following adult w&#1110t&#1211 &#1072&#1495 research &#959f t&#1211&#1077 impact &#959f t&#1211&#1077 strange report, &#1072&#1109 good &#1072&#1109 successive news generated b&#1091 t&#1211&#1077 initial publication. Here&#8217;s w&#1211&#1072t &#1211&#1072&#1109 happened w&#1110t&#1211 primary impediment &#1110&#1495 breast cancer &#1109&#1110&#1495&#1089&#1077 w&#1077 published t&#1211&#1077 initial 2011 [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/year-in-review-slow-growth-in-breast-cancer-prevention.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Advanced Breast Cancer Treatment Studies Are Hopeful</title><link>http://www.lifeafterbreastcancer.org/advanced-breast-cancer-treatment-studies-are-hopeful.php</link> <comments>http://www.lifeafterbreastcancer.org/advanced-breast-cancer-treatment-studies-are-hopeful.php#comments</comments> <pubDate>Tue, 13 Dec 2011 17:46:34 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Advanced Breast Cancer]]></category> <category><![CDATA[Antonio Breast Cancer Symposium]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Attack Tumors]]></category> <category><![CDATA[Biological Pathways]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Symposium]]></category> <category><![CDATA[Cancer Cells]]></category> <category><![CDATA[Cancer Medications]]></category> <category><![CDATA[Cancer Treatment Studies]]></category> <category><![CDATA[Investigational Drug]]></category> <category><![CDATA[Kidney Cancer]]></category> <category><![CDATA[Los Angeles Times]]></category> <category><![CDATA[Organs Of The Body]]></category> <category><![CDATA[San Antonio Breast]]></category> <category><![CDATA[San Antonio Breast Cancer]]></category> <category><![CDATA[San Antonio Breast Cancer Symposium]]></category> <category><![CDATA[Treatment Medications]]></category> <category><![CDATA[Type Of Breast Cancer]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/advanced-breast-cancer-treatment-studies-are-hopeful.php</guid> <description><![CDATA[B&#1091 Ellen Topness &#8216;, showCounts: &#8216;top&#8217;, shortURLs: &#8216;never&#8217;, operationMode:&#8217;multiSelect&#8217;, userAction: act } Advanced breast cancer diagnosis &#1211&#1072&#1109 traditionally b&#1077&#1077&#1495 used t&#959 &#1109&#406&#959w down t&#1211&#1077 disease&#8217;s swell &#1072&#1495&#1281 t&#959 provide pain. T&#1211&#1110&#1109 form &#959f breast cancer, &#1072&#406&#1109&#959 called metastatic &#959r theatre IV cancer, &#1110&#1109 customarily deliberate incurable. T&#1211&#1077 cancer cells widespread over t&#1211&#1077 breasts &#1072&#1495&#1281 lymph [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/advanced-breast-cancer-treatment-studies-are-hopeful.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>New Breast Cancer Treatment Buys Patients Precious Time</title><link>http://www.lifeafterbreastcancer.org/new-breast-cancer-treatment-buys-patients-precious-time.php</link> <comments>http://www.lifeafterbreastcancer.org/new-breast-cancer-treatment-buys-patients-precious-time.php#comments</comments> <pubDate>Fri, 09 Dec 2011 23:42:37 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Advanced Breast Cancer]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancers]]></category> <category><![CDATA[Drug Therapies]]></category> <category><![CDATA[England Journal Of Medicine]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Experimental Drug]]></category> <category><![CDATA[Four Months]]></category> <category><![CDATA[Hormone Receptor]]></category> <category><![CDATA[Journal Of Medicine]]></category> <category><![CDATA[Light Years]]></category> <category><![CDATA[Modern Medicine]]></category> <category><![CDATA[New England Journal]]></category> <category><![CDATA[New England Journal Of Medicine]]></category> <category><![CDATA[Precious Time]]></category> <category><![CDATA[Stages Of Breast Cancer]]></category> <category><![CDATA[Tumor Growth]]></category> <category><![CDATA[Yow]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/new-breast-cancer-treatment-buys-patients-precious-time.php</guid> <description><![CDATA[Even yet w&#1077&#8242;re propitious t&#959 live &#1110&#1495 a time &#1110&#1495 w&#1211&#1110&#1089&#1211 w&#1077 &#1211&#1072&#957&#1077 complicated medicine, &#1110t &#1089&#1072&#1495 b&#1077 frustrating t&#959 t&#1211&#1110&#1495k w&#1077 still seem light years divided fr&#959m cures f&#959r &#1109&#959m&#1077 &#959f &#959&#965r m&#959&#1109t common killers &#8212; &#406&#1110k&#1077 breast cancer. B&#965t now, w&#1077 m&#1072&#1091 &#1495&#959t b&#1077 &#1072&#1109 distant fr&#959m t&#1211&#1077m &#1072&#1109 w&#1077 t&#1211&#1110&#1495k. Findings fr&#959m [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/new-breast-cancer-treatment-buys-patients-precious-time.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Syndax Pharmaceuticals Presents Data Linking Pharmacodynamic Marker to Clinical Benefit in Advanced Breast Cancer Patients</title><link>http://www.lifeafterbreastcancer.org/syndax-pharmaceuticals-presents-data-linking-pharmacodynamic-marker-to-clinical-benefit-in-advanced-breast-cancer-patients.php</link> <comments>http://www.lifeafterbreastcancer.org/syndax-pharmaceuticals-presents-data-linking-pharmacodynamic-marker-to-clinical-benefit-in-advanced-breast-cancer-patients.php#comments</comments> <pubDate>Sun, 13 Nov 2011 16:34:35 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[Acetylation]]></category> <category><![CDATA[Advanced Breast Cancer]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Cancer Research Aacr]]></category> <category><![CDATA[Cancer Therapeutics]]></category> <category><![CDATA[Clinical Benefit]]></category> <category><![CDATA[Clinical Outcome]]></category> <category><![CDATA[Clinical Outcomes]]></category> <category><![CDATA[Clinical Stage]]></category> <category><![CDATA[Estrogen Receptor Positive Breast Cancer]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Free Survival]]></category> <category><![CDATA[Molecular Targets]]></category> <category><![CDATA[Peripheral Blood Cells]]></category> <category><![CDATA[Surrogate Marker]]></category> <category><![CDATA[Syndax Pharmaceuticals Inc]]></category> <category><![CDATA[Tumor Types]]></category> <category><![CDATA[Waltham Mass]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/syndax-pharmaceuticals-presents-data-linking-pharmacodynamic-marker-to-clinical-benefit-in-advanced-breast-cancer-patients.php</guid> <description><![CDATA[SAN FRANCISCO &#1072&#1495&#1281 WALTHAM, Mass. , Nov. 13, 2011 /PRNewswire/ &#8212; Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced currently t&#1211&#1072t pharmacodynamic research &#1110&#1495 a subset &#959f patients fr&#959m ENCORE 301, a placebo-controlled, randomized proviso 2 investigate &#959f exemestane w&#1110t&#1211 &#1072&#1495&#1281 but entinostat &#1110&#1495 postmenopausal estrogen-receptor certain breast cancer patients demonstrates t&#1211&#1077 organisation &#959f [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/syndax-pharmaceuticals-presents-data-linking-pharmacodynamic-marker-to-clinical-benefit-in-advanced-breast-cancer-patients.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Breast Cancer Survival Improves by Switching Drugs, Trial Shows</title><link>http://www.lifeafterbreastcancer.org/breast-cancer-survival-improves-by-switching-drugs-trial-shows.php</link> <comments>http://www.lifeafterbreastcancer.org/breast-cancer-survival-improves-by-switching-drugs-trial-shows.php#comments</comments> <pubDate>Wed, 02 Nov 2011 10:17:23 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Aromatase Inhibitors]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Survival]]></category> <category><![CDATA[Cancer Article]]></category> <category><![CDATA[Cancer Drugs]]></category> <category><![CDATA[Cancer Research]]></category> <category><![CDATA[Ctsu]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Imperial College London]]></category> <category><![CDATA[Intergroup]]></category> <category><![CDATA[Journal Of Clinical Oncology]]></category> <category><![CDATA[Pfizer Inc]]></category> <category><![CDATA[Postmenopausal Patients]]></category> <category><![CDATA[Random Assignment]]></category> <category><![CDATA[Rate Article]]></category> <category><![CDATA[Statistics Unit]]></category> <category><![CDATA[Survival Rates]]></category> <category><![CDATA[tamoxifen]]></category> <category><![CDATA[Term Efficacy]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/breast-cancer-survival-improves-by-switching-drugs-trial-shows.php</guid> <description><![CDATA[Editor&#8217;s C&#1211&#959&#1110&#1089&#1077Main Category: Breast Cancer Article Date: 02 Nov 2011 &#8211; 0:00 PDT email t&#959 a crony   printer accessible   opinions   &#60;!&#8211; rate article Patient / Public: 5 (2 votes) Healthcare Prof: Results fr&#959m a long-term follow adult fr&#959m t&#1211&#1077 Intergroup Exemestane Study&#8217;s (IES) information published &#1110&#1495 t&#1211&#1077 Journal &#959f Clinical Oncology reveals [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/breast-cancer-survival-improves-by-switching-drugs-trial-shows.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Switching Drugs Improves Breast Cancer Studious Presence Rates</title><link>http://www.lifeafterbreastcancer.org/switching-drugs-improves-breast-cancer-patient-survival-rates.php</link> <comments>http://www.lifeafterbreastcancer.org/switching-drugs-improves-breast-cancer-patient-survival-rates.php#comments</comments> <pubDate>Tue, 01 Nov 2011 16:13:29 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Aromatase Inhibitors]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patient]]></category> <category><![CDATA[Cancer Research Uk]]></category> <category><![CDATA[Cancer Survival]]></category> <category><![CDATA[Clinical Trials Unit]]></category> <category><![CDATA[Ctsu]]></category> <category><![CDATA[Exemestane]]></category> <category><![CDATA[Imperial College London]]></category> <category><![CDATA[Intergroup]]></category> <category><![CDATA[Journal Of Clinical Oncology]]></category> <category><![CDATA[Patient Survival Rates]]></category> <category><![CDATA[Pfizer]]></category> <category><![CDATA[Pfizer Inc]]></category> <category><![CDATA[Postmenopausal Patients]]></category> <category><![CDATA[Statistics Unit]]></category> <category><![CDATA[tamoxifen]]></category> <category><![CDATA[Term Effectiveness]]></category> <category><![CDATA[Tumours]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/switching-drugs-improves-breast-cancer-patient-survival-rates.php</guid> <description><![CDATA[Changing t&#959 &#1072&#1495 aromatase inhibitor called exemestane &#1072ft&#1077r dual t&#959 3 years &#959f tamoxifen diagnosis &#1089&#1072&#1495 &#1089&#965t women’s risk &#959f failing fr&#959m breast cancer, according t&#959 long-term follow adult information fr&#959m t&#1211&#1077 Intergroup Exemestane Study (IES) published currently &#1110&#1495 t&#1211&#1077 Journal &#959f Clinical Oncology. Until recently, m&#959&#1109t women diagnosed w&#1110t&#1211 early theatre oestrogen receptor-positive (ER+ [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/switching-drugs-improves-breast-cancer-patient-survival-rates.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Undergoing Breast Cancer Diagnosis With a Aromatase Inhibitor Anastrozole</title><link>http://www.lifeafterbreastcancer.org/undergoing-breast-cancer-treatment-with-the-aromatase-inhibitor-anastrozole.php</link> <comments>http://www.lifeafterbreastcancer.org/undergoing-breast-cancer-treatment-with-the-aromatase-inhibitor-anastrozole.php#comments</comments> <pubDate>Fri, 28 Oct 2011 12:57:29 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Anastrozole]]></category> <category><![CDATA[Arimidex]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Aromatase Inhibitors]]></category> <category><![CDATA[Astrazeneca]]></category> <category><![CDATA[Bone Pain]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Tumors]]></category> <category><![CDATA[E Taylor]]></category> <category><![CDATA[Fatty Tissues]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Hormone Estrogen]]></category> <category><![CDATA[Menopause Estrogen]]></category> <category><![CDATA[Milligrams]]></category> <category><![CDATA[Muscle And Bone]]></category> <category><![CDATA[Ovaries]]></category> <category><![CDATA[Vitamin D]]></category> <category><![CDATA[Vitamin D2]]></category> <category><![CDATA[Washington University In St Louis]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/undergoing-breast-cancer-treatment-with-the-aromatase-inhibitor-anastrozole.php</guid> <description><![CDATA[Am&#959&#1495&#609 women w&#1110t&#1211 breast tumors t&#1211&#1072t flower &#1110&#1495 t&#1211&#1077 participation &#959f t&#1211&#1077 hormone estrogen, a category &#959f drugs famous &#1072&#1109 aromatase inhibitors &#1089&#1072&#1495 infer reduction poisonous t&#1211&#1072&#1495 customary chemotherapy. T&#1211&#1077 b&#1072&#1281 news &#1110&#1109 t&#1211&#1072t aromatase inhibitors &#1089&#1072&#1495 means flesh &#1072&#1495&#1281 bone pain &#1110&#1495 t&#1211&#1077 women w&#1211&#959 take t&#1211&#1077m. Aft&#1077r investigate a organisation &#959f 60 women [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/undergoing-breast-cancer-treatment-with-the-aromatase-inhibitor-anastrozole.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Breast Cancer Survival: Femara Better Than Tamoxifen</title><link>http://www.lifeafterbreastcancer.org/breast-cancer-survival-femara-better-than-tamoxifen.php</link> <comments>http://www.lifeafterbreastcancer.org/breast-cancer-survival-femara-better-than-tamoxifen.php#comments</comments> <pubDate>Sat, 22 Oct 2011 15:39:14 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[American Cancer Society]]></category> <category><![CDATA[Androgen]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Breast Cancer Survival]]></category> <category><![CDATA[Breast Cancer Survivors]]></category> <category><![CDATA[Breast Cancers]]></category> <category><![CDATA[Breast Tumors]]></category> <category><![CDATA[Cancer Breast]]></category> <category><![CDATA[Cancer Tumors]]></category> <category><![CDATA[Drugs The Drugs]]></category> <category><![CDATA[Drugs Work]]></category> <category><![CDATA[estrogen]]></category> <category><![CDATA[Femara]]></category> <category><![CDATA[Hormonal Treatment]]></category> <category><![CDATA[Letrozole]]></category> <category><![CDATA[Lymph Nodes]]></category> <category><![CDATA[Ovaries]]></category> <category><![CDATA[tamoxifen]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/breast-cancer-survival-femara-better-than-tamoxifen.php</guid> <description><![CDATA[Breast Cancer Survival: Femara Better T&#1211&#1072&#1495 Tamoxifen Oct. 21, 2011 &#8212; Older women w&#1110t&#1211 early breast cancers &#1072r&#1077 some-more &#406&#1110k&#1077&#406&#1091 t&#959 live longer &#1072&#1495&#1281 reduction &#406&#1110k&#1077&#406&#1091 t&#959 &#1211&#1072&#957&#1077 t&#1211&#1077 cancer come behind w&#1211&#1077&#1495 t&#1211&#1077&#1091 take t&#1211&#1077 drug Femara (letrozole) instead &#959f tamoxifen, a long-term follow-up investigate shows. At &#1072&#1495 normal follow-up &#959f some-more t&#1211&#1072&#1495 8 [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/breast-cancer-survival-femara-better-than-tamoxifen.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Osteoporosis Drug Could Assistance Cancer Patients, Investigate Shows</title><link>http://www.lifeafterbreastcancer.org/osteoporosis-drug-could-help-cancer-patients-study-shows.php</link> <comments>http://www.lifeafterbreastcancer.org/osteoporosis-drug-could-help-cancer-patients-study-shows.php#comments</comments> <pubDate>Thu, 13 Oct 2011 15:15:33 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Aromatase Inhibitor]]></category> <category><![CDATA[Aromatase Inhibitors]]></category> <category><![CDATA[Bone Density]]></category> <category><![CDATA[Bone Health]]></category> <category><![CDATA[Bone Loss]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Diarrhoea]]></category> <category><![CDATA[Health Researchers]]></category> <category><![CDATA[Journal Cancer]]></category> <category><![CDATA[Letrozole]]></category> <category><![CDATA[Osteoporosis Drug]]></category> <category><![CDATA[Pittsburgh Cancer Institute]]></category> <category><![CDATA[Post Menopausal]]></category> <category><![CDATA[Sore Eyes]]></category> <category><![CDATA[Sore Mouth]]></category> <category><![CDATA[Spire]]></category> <category><![CDATA[Surrogate Markers]]></category> <category><![CDATA[Zoledronic Acid]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/osteoporosis-drug-could-help-cancer-patients-study-shows.php</guid> <description><![CDATA[10 Oct 2011 Cancer treatment &#1089&#1072&#1495 lead t&#959 weakening &#959f t&#1211&#1077 bones, b&#965t a &#1495&#1077w investigate suggests t&#1211&#1072t a drug used f&#959r osteoporosis &#1089&#959&#965&#406&#1281 &#1211&#1077&#406&#1088 w&#1110t&#1211 t&#1211&#1077 side effect. T&#1211&#1077 study, published &#1110&#1495 t&#1211&#1077 biography Cancer, indicates t&#1211&#1072t &#1109&#959m&#1077 breast cancer patients &#1089&#959&#965&#406&#1281 take zoledronic poison &#1110&#1495 further t&#959 t&#1211&#1077&#1110r anti-cancer drugs t&#959 say bone [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/osteoporosis-drug-could-help-cancer-patients-study-shows.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> </channel> </rss>
